Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mark Norman Levine"'
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3269-3277 (2024)
Introduction: Although virtual care (VC) has become an integral part of oncology care and healthcare delivery, clinicians’ perspectives on and satisfaction with this modality are not well understood. Methods: Using a National Network Forum framewor
Externí odkaz:
https://doaj.org/article/f1d343f55cc04104ae29ac03eb700789
Autor:
Paola Muti, Andrea Sacconi, Claudio Pulito, Giulia Orlandi, Sara Donzelli, Aldo Morrone, James Jiulian, Gerard P. Cox, Martin Kolb, Gregory Pond, Peter Kavsak, Mark Norman Levine, Giovanni Blandino, Sabrina Strano
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-12 (2022)
Abstract Background Malignant pleural mesothelioma is a highly aggressive tumor associated with asbestos exposure. There are few effective treatment options for mesothelioma, and patients have a very poor prognosis. Mesothelioma has the potential to
Externí odkaz:
https://doaj.org/article/881490acf3754d43aca0d1fbffd35fcd
Autor:
Srikala S. Sridhar, Nicholas Power, Rodney H. Breau, Susanna Y. Cheng, Gregory Russell Pond, Peter W. M. Chung, Ur Metser, Mark Norman Levine, Som D. Mukherjee
Publikováno v:
Journal of Clinical Oncology. 41:460-460
460 Background: Muscle invasive bladder cancer (MIBC) is an aggressive local disease where initial staging with conventional CT imaging is often suboptimal. To explore the role of PET-CT in both staging MIBC and assessing response to neoadjuvant chem
Autor:
Aly-Khan A. Lalani, Anand Swaminath, Gregory Russell Pond, Scott Carlyle Morgan, Arun Azad, William Chu, Eric Winquist, Anil Kapoor, Michael Bonert, Jonathan L. Bramson, Michael G. Surette, Christina M. Canil, Shankar Siva, Georg A. Bjarnason, Mark Norman Levine, Jim Wright, Sebastien J. Hotte
Publikováno v:
Journal of Clinical Oncology. 41:TPS750-TPS750
TPS398 Background: Randomized data from the interferon era demonstrated survival benefits of cytoreductive nephrectomy (CN) in patients with metastatic renal cell carcinoma (mRCC). Results from SURTIME and CARMENA, conducted in the VEGF-targeted ther
Autor:
Timothy Joseph Whelan, Sally Smith, Torsten O. Nielsen, Sameer Parpia, Anthony W. Fyles, Anita Bane, Fei-Fei Liu, Laval Grimard, Christiaan Stevens, Julie Bowen, Sawyna Provencher, Eileen Rakovitch, Valerie Theberge, Anna Marie Mulligan, Mohamed A. Akra, K. David Voduc, Tarek Hijal, Ian S. Dayes, Gregory Russell Pond, Mark Norman Levine
Publikováno v:
Journal of Clinical Oncology. 40:LBA501-LBA501
LBA501 Background: Adjuvant breast RT is usually prescribed following BCS to reduce the risk of local recurrence (LR). However, this treatment is inconvenient, costly, and associated with acute and late toxicity. Traditional clinical pathological fac
Autor:
Pablo Emilio Serrano Aybar, Sameer Parpia, Marko Simunovic, Emmanuelle Duceppe, Maria Ines Pinto-Sanchez, Mohit Bhandari, Mark Norman Levine
Publikováno v:
Journal of Clinical Oncology. 40:482-482
482 Background: Nutritional status is a major determinant of outcomes following surgery. Perioperative nutritional supplementation may improve postoperative outcomes, however, studies on the topic have led to controversial results. Methods: Single-ce